TCRT:NASDAQ, Alaunos Therapeutics, Inc.

TCRT stock overview

Alaunos Therapeutics, Inc. (TCRT:NASDAQ) closed at $1.63 on November 13, 2026, up 0.62% on the day. The stock trades 63.8% below its 52-week high of $4.50 and 126.4% above its 52-week low of $0.720. Over the past year, it lost 49.4%. Alaunos Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$1.63
Day change
+0.62%
Volume
33,798
Average volume
7,436,029
Market cap
5M+
52-week range
$0.720 – $4.50
50-day average
$1.64
200-day average
$2.27

Price action over the past year

In 252 trading sessions since November 13, 2025, TCRT closed higher on 103 days (41%). Its best day was October 13, 2026 (+188.57%) and its worst was October 14, 2026 (-31.68%). The stock moved 10% or more in a single session 23 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

TCRT news

About Alaunos Therapeutics, Inc.

ZIOPHARM Oncology Inc is a biotechnology company that acquires, develops, and commercializes cancer therapies. Its preclinical and clinical pipeline focuses on treating hematological and solid tumor malignancies using cellular therapeutics. Ziopharm engages in gene therapy systems with its partner Intrexon and collaborators at the University of Texas. To fund the development of its product candidates, the company engages in contractual arrangements with licensing partners both in the United States and abroad.

Similar stocks

Find more stocks like TCRT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.